Beovu 120mg/ml
As listed in the register: Beovu 120mg/ml, Injektionslösung in Fertigspritze
120mg/ml ·
- Prescription only
- Eyes and ears
- Active substance
- Brolucizumabum
- Used in
- Eyes and ears
- Made by
- Novartis Pharma Schweiz AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- altersbedingte Makuladegeneration (AMD) und diabetisches Makulaödem (DME)
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Novartis Pharma Schweiz AG |
|---|---|
| Active substance | Brolucizumabum |
| Used in | Eyes and ears |
| Strength | 120mg/ml |
| Classification | S01LA06 · Eyes and ears |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Beovu 120mg/ml, Injektionslösung in Fertigspritze |
| Packs | 1 Fertigspritze(n) |
| Zulassungsnummer | 67244 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.